Abeona Therapeutics Inc.
ABEO
$5.56
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.54% | -296.43% | -104.74% | 1,004.76% | -29.44% |
| Total Depreciation and Amortization | -20.42% | 22.97% | 15.63% | -5.77% | 5.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -206.67% | 1,709.01% | 100.08% | -3,724.69% | 10.46% |
| Change in Net Operating Assets | -145.53% | 96.52% | -208.77% | 557.42% | 10.79% |
| Cash from Operations | -10.31% | 15.26% | -12.79% | -2.08% | -11.13% |
| Capital Expenditure | 18.91% | 54.25% | 13.13% | -107.07% | -131.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.91% | 117.24% | -139.11% | 2,728.45% | -71.18% |
| Cash from Investing | -48.05% | 114.78% | -141.46% | 3,600.17% | -77.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -30.00% | -50.83% | 54.45% | 23.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 80.65% | 84.42% |
| Cash from Financing | -161.48% | -30.00% | -50.81% | 55.07% | 27.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.59% | 94.07% | -154.64% | 2,088.94% | -197.25% |